Inhibiting HLA-B27 homodimer-driven immune cell inflammation in spondylarthritis

Arthritis and Rheumatism

Volumn 64, Issue 10, 2012, Pages 3139-3149

  Payeli, Sravan K ^a   Kollnberger, Simon ^b   Belaunzaran, Osiris Marroquin ^a   Thiel, Markus ^a   McHugh, Kirsty ^b   Giles, Joanna ^b   Shaw, Jacqueline ^b   Kleber, Sascha ^a   Ridley, Anna ^b   Wong Baeza, Isabel ^b   Keidel, Sarah ^b   Kuroki, Kimiko ^c   Maenaka, Katsumi ^c   Wadle, Andreas ^a   Renner, Christoph ^a   Bowness, Paul ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CYTOKINE; HLA B27 ANTIGEN; HOMODIMER; INTERLEUKIN 17; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL2; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HD6; UNCLASSIFIED DRUG;

ARTICLE; CD4+ T LYMPHOCYTE; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; HEAVY CHAIN; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOCOMPETENT CELL INFLAMMATION; INFLAMMATION; MONONUCLEAR CELL; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGE DISPLAY; PRIORITY JOURNAL; SPONDYLARTHRITIS; SURFACE PLASMON RESONANCE; SYNOVIAL FLUID;

ARTHRITIS, RHEUMATOID; CELL LINE; HLA-B27 ANTIGEN; HUMANS; INFLAMMATION; KILLER CELLS, NATURAL; SPONDYLARTHRITIS; T-LYMPHOCYTES;

EID: 84869026015     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.34538     Document Type: Article

References (28)

1. Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC, Sturrock RD. Ankylosing spondylitis and HL-A 27. Lancet 1973; 1:904-7.
2. Brown MA, Pile KD, Kennedy LG, Calin A, Darke C, Bell J, et al. HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Ann Rheum Dis 1996;55: 268-70. (Pubitemid 26120706)
3. Gaston H. Mechanisms of disease: the immunopathogenesis of spondyloarthropathies. Nat Clin Pract Rheumatol 2006; 2: 383-92.
4. Allen RL, Bowness P, McMichael A. The role of HLA-B27 in spondyloarthritis. Immunogenetics 1999; 50: 220-7. (Pubitemid 30099527)
5. Madden DR. The three-dimensional structure of peptide-MHC complexes. Annu Rev Immunol 1995; 13: 587-622.
6. Allen RL, O'Callaghan CA, McMichael AJ, Bowness P. HLA-B27 can form a novel -2-microglobulin-free heavy chain homodimer structure. J Immunol 1999; 162: 5045-8. (Pubitemid 29307101)
7. Bird LA, Peh CA, Kollnberger S, Elliott T, McMichael AJ, Bowness P. Lymphoblastoid cells express HLA-B27 homodimers both intracellularly and at the cell surface following endosomal recycling. Eur J Immunol 2003; 33: 748-59. (Pubitemid 36367678)
8. Capps GG, Robinson BE, Lewis KD, Zuniga MC. In vivo dimeric association of class I MHC heavy chains: possible relationship to class I MHC heavy chain-2-microglobulin dissociation. J Immunol 1993; 151: 159-69. (Pubitemid 23206981)
9. Powis SJ, Santos SG, Antoniou AN. Biochemical features of HLA-B27 and antigen processing. Adv Exp Med Biol 2009;649: 210-6.
10. Kollnberger S, Bird L, Sun MY, Retiere C, Braud VM, McMichael A, et al. Cell-surface expression and immune receptor recognition of HLA-B27 homodimers. Arthritis Rheum 2002; 46: 2972-82. (Pubitemid 35315891)
11. Kollnberger S, Chan A, Sun MY, Chen LY, Wright C, di Gleria K, et al. Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterotrimers, is independent of the sequence of bound peptide. Eur J Immunol 2007; 37: 1313-22. (Pubitemid 46925315)
12. Kollnberger S, Bowness P. The role of B27 heavy chain dimer immune receptor interactions in spondyloarthritis. Adv Exp Med Biol 2009; 649: 277-85.
13. Lanier LL. NK cell recognition. Annu Rev Immunol 2005;23: 225-74. (Pubitemid 40563170)
14. Dohring C, Scheidegger D, Samaridis J, Cella M, Colonna M. A human killer inhibitory receptor specific for HLA-A1,2. J Immunol 1996; 156: 3098-101. (Pubitemid 26123520)
15. Hansasuta P, Dong T, Thananchai H, Weekes M, Willberg C, Aldemir H, et al. Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific. Eur J Immunol 2004; 34: 1673-9. (Pubitemid 39256049)
16. Chan AT, Kollnberger SD, Wedderburn LR, Bowness P. Expansion and enhanced survival of natural killer cells expressing the killer immunoglobulin-like receptor KIR3DL2 in spondylarthritis. Arthritis Rheum 2005; 52: 3586-95. (Pubitemid 41612228)
17. Bowness P, Ridley A, Shaw J, Chan A, Wong Baeza I, Fleming M, et al. Th17 cells expressing KIR3DL2-and responsive to HLAB27 homodimers are increased in ankylosing spondylitis. J Immunol 2011; 186: 2672-80.
18. Kollnberger S, Bird LA, Roddis M, Hacquard-Bouder C, Kubagawa H, Bodmer HC, et al. HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors. J Immunol 2004; 173: 1699-710. (Pubitemid 38971601)
19. Taurog JD, Dorris ML, Satumtira N, Tran TM, Sharma R, Dressel R, et al. Spondylarthritis in HLA-B27/human -2-microglobulin- transgenic rats is not prevented by lack of CD8. Arthritis Rheum 2009; 60: 1977-84.
20. Stam NJ, Spits H, Ploegh HL. Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J Immunol 1986; 137: 2299-306. (Pubitemid 16020728)
21. Perosa F, Luccarelli G, Prete M, Favoino E, Ferrone S, Dammacco F. -2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide. J Immunol 2003; 171: 1918-26. (Pubitemid 36966475)
22. Raine T, Brown D, Bowness P, Hill Gaston JS, Moffett A, Trowsdale J, et al. Consistent patterns of expression of HLA class I free heavy chains in healthy individuals and raised expression in spondyloarthropathy patients point to physiological and pathological roles. Rheumatology (Oxford) 2006; 45: 1338-44. (Pubitemid 44605466)
23. Tsai WC, Chen CJ, Yen JH, Ou TT, Tsai JJ, Liu CS, et al. Free HLA class I heavy chain-carrying monocytes - a potential role in the pathogenesis of spondyloarthropathies. J Rheumatol 2002;29: 966-72. (Pubitemid 34493502)
24. Held G, Matsuo M, Epel M, Gnjatic S, Ritter G, Lee SY, et al. Dissecting cytotoxic T cell responses towards the NY-ESO-1 protein by peptide/MHC-specific antibody fragments. Eur J Immunol 2004; 34: 2919-29. (Pubitemid 39430167)
25. Hoogenboom HR, Lutgerink JT, Pelsers MM, Rousch MJ, Coote J, van Neer N, et al. Selection-dominant and nonaccessible epitopes on cell-surface receptors revealed by cell-panning with a large phage antibody library. Eur J Biochem 1999; 260: 774-84. (Pubitemid 29148644)
26. Boyson JE, Erskine R, Whitman MC, Chiu M, Lau JM, Koopman LA, et al. Disulfide bond-mediated dimerization of HLA-G on the cell surface. Proc Natl Acad Sci U S A 2002; 99: 16180-5. (Pubitemid 35462769)
27. Wright C, Edelmann M, diGleria K, Kollnberger S, Kramer H, McGowan S, et al. Ankylosing spondylitis monocytes show upregulation of proteins involved in inflammation and the ubiquitin proteasome pathway. Ann Rheum Dis 2009; 68: 1626-32.
28. Sieper J. Developments in the scientific and clinical understanding of the spondyloarthritides. Arthritis Res Ther 2009;11:208.